• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Journal Scan: Help for hypertrophic cardiomyopathy in cats

February 6, 2017
Michael Nappier, DVM, DABVP

MYK-461 shows promise as a novel veterinary approach to treating the disease at a molecular level.

Dorottya Mathe/ Shutterstock.comBackground

Hypertrophic cardiomyopathy (HCM) is an inherited heart disease that is common in people and in cats. In both species, HCM is characterized by a thickening of the left ventricle caused by increased contractility and decreased relaxation of the cardiac muscle. This can also often result in left ventricular outflow tract (LVOT) obstruction.

Current treatments for cats are largely symptomatic and do not alter the course of the disease. However, MYK-461 is a novel drug that inhibits sarcomere contractility to address the causes at a molecular level.

Design

Five cats previously diagnosed with feline HCM and LVOT obstruction were anesthetized and underwent a baseline echocardiographic examination. The cats were then given atropine and an infusion of isoproterenol to bring their heart rates back to the pre-anesthesia values where LVOT obstruction was present and underwent another complete echocardiographic examination.

Next, the cats received an infusion of MYK-461. Echocardiography was performed at several time points during different rates of infusion. The infusions of both MYK-461 and isoproterenol were then stopped. Once their heart rates returned to baseline anesthetized levels, the cats underwent a final echocardiographic examination. All cats recovered uneventfully from anesthesia.

Results

MYK-461 administration reduced fractional shortening while maintaining heart rate in all five study participants, thereby eliminating LVOT obstruction in the cats.

Advertisement

Significance

MYK-461 shows promise as a novel approach to treating HCM by working at a molecular level to decrease hypercontractility and increase muscle relaxation through inhibiting sarcomere contractility. Furthermore, MYK-461 was demonstrated to not have some of the negative effects of other commonly used negative inotropes, such as beta blockers and calcium channel blockers.

The researchers postulate that by attacking HCM at its molecular root, it may be possible to prevent disease progression in cats-a hypothesis that is more than just idle speculation. Although the authors don't mention it specifically, a previously published paper by some of the same authors showed MYK-461 as effectively preventing progression of HCM in mice.1

 

Stern JA, Markova S, Ueda Y, et al. A small molecule inhibitor of sarcomere contractility acutely relieves left ventricular outflow tract obstruction in feline hypertrophic cardiomyopathy. PLoS One 2016;11(12).

Click here to read the full article.

 

Reference

Green EM, Wakimoto H, Anderson RL, et al. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 2016;351(6273): 617-621.

Related Content:

CardiologyFeline Medicine
Chronic feline pain from all perspectives
Chronic feline pain from all perspectives
Q&A with a keynote: Elizabeth Colleran, DVM, DABVP (Feline)
Q&A with a keynote: Elizabeth Colleran, DVM, DABVP (Feline)
UC Davis study on eye diseases in kittens
UC Davis study on eye diseases in kittens

Advertisement

Latest News

An update on copper concerns in pet foods

Dental hacks to make every case more manageable

Q&A with a keynote: Walter Brown, RVTg, VTS, ECC

News wrap-up: This week’s headlines, plus dvm360® launches its first CE podcast

View More Latest News
Advertisement